403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Hikma Donates $1.1 Million In Medicines To Support Syria
(MENAFN- Jordan News Agency)
Amman, Nov. 10 (Petra) – Hikma Pharmaceuticals announced its donation of an emergency shipment of medicines worth $1.1 million as part of an aid convoy launched under Royal directives through the Jordan Hashemite Charity Organization to support the people of Syria.
According to a statement issued by Hikma on Monday, the shipment includes a range of essential medicines, such as anti-infectives, pain relievers, and other treatments covering various therapeutic areas, for both oral and inpatient use.
The statement added that the donation underscores Hikma's commitment to strengthening its humanitarian role and supporting communities in need during difficult times, in line with its mission to make better health more accessible every day.
Amman, Nov. 10 (Petra) – Hikma Pharmaceuticals announced its donation of an emergency shipment of medicines worth $1.1 million as part of an aid convoy launched under Royal directives through the Jordan Hashemite Charity Organization to support the people of Syria.
According to a statement issued by Hikma on Monday, the shipment includes a range of essential medicines, such as anti-infectives, pain relievers, and other treatments covering various therapeutic areas, for both oral and inpatient use.
The statement added that the donation underscores Hikma's commitment to strengthening its humanitarian role and supporting communities in need during difficult times, in line with its mission to make better health more accessible every day.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment